Pharma Industry News

information-analysis-insights

  • Home
  • Directories
  • Reports
  • Know Us
  • News
    • New Projects
    • New Launches
    • Formulations
    • Insights
    • New Drugs
    • BioTechnology
    • Ayurvedic Drugs

Cipla

Cipla receives USFDA approval for Ambrisentan

May 15, 2019 IbisResearch 0

Cipla has received the final USFDA approval for the Abbreviated New Drug Application (ANDA) for their Ambrisentan Tablets, 5 mg and 10 mg. The drug […]

Cipla receives USFDA approval for Medroxyprogesterone injectable

January 30, 2019 IbisResearch 0

Cipla has received final USFDA approval for Medroxyprogesterone injectable for prevention of pregnancy in the markets of America. The injection Medroxyprogesterone injectable 150mg/million is a […]

Cipla plans revival of old unit in Pithampur

January 26, 2019 IbisResearch 0

Cipla Ltd is planning to set up a pharma unit in Pithampur in Dhar district of Madhya Pradesh. The project involves reviving the old plant […]

Cipla receives USFDA approval for Albendazole Tablets in USA

October 15, 2018 IbisResearch 0

Cipla has received final USFDA approval for its Abbreviated New Drug Application (ANDA) for Albendazole Tablets in strength of 200mg. The drug Albendazole Tablets 200mg […]

Cipla signs agreement with Stempeutics Research for Stempeucel

June 1, 2018 IbisResearch 0

Cipla Ltd has signed an agreement with biotech firm Stempeutics Research for its stem cell therapy product Stempeucel, indicated for treating critical limb ischemia. Under […]

Cipla to launch Entecavir tablet in USA

December 19, 2016 IbisResearch 0

Cipla has received final USFDA approval to market Entecavir tablets used for treatment of Hepatitis B infection. The tablets are generic versions of Bristol-Myers Suibb’s […]

Cipla receives final ANDA approval for Darifenacin extended-release

September 20, 2016 IbisResearch 0

Cipla has received final USFDA approval for its Abbreviated New Drug Application (ANDA) for Darifenacin extended-release tablets. Darifenacin extended-release tablets are AB-rated generic equivalents of […]

Cipla receives USFDA approval for generic Bupropion Hydrochloride extended release tablets

September 19, 2016 IbisResearch 0

Cipla has received final USFDA approval to market generic Bupropion Hydrochloride extended release tablets used for treatment of major depressive disorder through its subsidiary InvaGen […]

Cipla launches anti-hepatisis drug Ledipasvir

January 3, 2016 IbisResearch 0

Cipla Ltd has launched the generic version of anti-hepatitis drug Ledipasvir-Sofosbuvir in the domestic market. The drug is used for treating hepatitis C virus. About […]

Segments

Ayurvedic Drugs
BioTechnology
Bulk Drugs
CRAMS
Formulations

Recent Posts

  • New Research Centre to be developed in Lavale
  • Maharashtra government plans new bulk drug park in Raigad
  • Karnataka government plans new Bio Technology park near Bengaluru
  • Union Government incentives local API production
  • Perennial Medicare Pvt Ltd

Search

About

Ibis Research-which maintains this site - aims to tracks core industrial sectors. It records Indian Pharmaceutical sector news, updates, technology trends, company profiles, updates address directories, tracks new project investments, posting updates on the latest development.

It provides timely information, analysis and insights.

This website tracks state government policies, employment opportunities in the sector, industry climate and economy forecast etc.,

New Projects
  • Maharashtra government plans new bulk drug park in Raigad

    November 21, 2020 0
  • Karnataka government plans new Bio Technology park near Bengaluru

    August 1, 2020 0
  • Desano Pharmaceuticals plans new manufacturing facility in Harohalli

    November 29, 2019 0
  • Union Government to develop a bulk drug park in Himachal Pradesh

    November 26, 2019 0
  • Suven Life Science plans expansion programme

    September 22, 2019 0
Latest News
  • New Research Centre to be developed in Lavale
  • Maharashtra government plans new bulk drug park in Raigad
  • Karnataka government plans new Bio Technology park near Bengaluru
  • Union Government incentives local API production
  • Perennial Medicare Pvt Ltd

Copyright © 2023 | WordPress Theme by MH Themes